Fasciíte necrosante pós-osteossíntese de fratura transtrocantérica do fêmur
Introduction
Necrotizing fasciitis is a rare infection, misdiagnosed as a benign infection. The physician must have a high degree knowledgeable of the clinical presentation and treatment. Timely diagnosis, surgical debridement and broad-spectrum parenteral antibiotic therapy are the keys to proper treatment.
The objective of this study was to describe the fatal course of a patient who developed necrotizing fasciitis after osteosynthesis of transtrochanteric fracture and to review the literature of this serious infection.
Case report
Seventy-one year old female with a history of falling in the bathroom. The patient was in pain, unable to walk, with shortening, external rotation and limited range of motion of the left leg. Presented with arterial hypertension, diabetes, congestive heart failure, liver cirrhosis, schistosomiasis with portal hypertension and thrombocytopenia. Radiographs of the pelvis and left hip showed an unstable transtrochanteric fracture (31-A2.2/AO-ASIF).
The patient was operated on the fourth day of hospitalization after her release of the medical clinic. Relative stability of the fracture (osteosynthesis with DHS screw) and postoperative control in the ICU were obtained.
On the second day postoperatively, the patient was discharged from the ICU and started motor physical therapy with progressive partial load with walker. She was discharged on the eighth hospital day.
Six days after discharge, the patient returned to the hospital complaining of pain in her left leg, with edema, ecchymosis and swelling of the left calf. The duplex scan of the lower limbs depicted deep vein thrombosis (DVT) in the left lower limb.
Anticoagulation with enoxaparin SC, followed by warfarin PO, was initiated.
After two days, the patient reported persistent pain in the medial aspect of her left thigh, with fever (38 • C). Absence of skin changes in the wound.
Laboratory tests were requested: hemoglobin: 7.5 g/dL, total leukocyte: 2400 mm -3 (bands: 7%, segmented: 82%); platelets: 46,000 mm −3 , RNI 1.94; APTT: 41/26, PCR: 28.7 mg/dL.
Progression the next day with hypotension (BP: 80 × 40 mmHg), prostration and appearance of blisters on the medial aspect of the left thigh. Absence of pain relief with the use of opioids. Started empirical antibiotic therapy (meropenem), with no improvement.
Suspicion of necrotizing fasciitis because of severe pain, rapid appearance of bullous lesions in her left thigh and refractoriness to analgesia.
Indication of debridement of the left leg, but the patient had blood dyscrasia (INR 7.36 and PTTA 73/26).
Changing antibiotics to intravenous tigecycline. The patient was referred on an emergency basis to the operating room for wide left leg fasciotomy, surgical debridement and collection of material for analysis (Figs. 1-3) .
Occurrence of severe septic shock refractory to the use of amines. The patient eventually died.
The results of blood cultures and samples collected during surgery identified multiresistant A. baumannii/haemolyticus. The germ was only sensitive to trimethoprimsulfamethoxazole, tetracycline and tigecycline. 
Discussion
Necrotizing fasciitis was described in 1871 by the U.S. Army surgeon Joseph Jones. In 1883, Fournier identified necrotizing fasciitis that affects the perineum and external genitalia. But it was Ben Wilson, in 1952, who described the superficial fascia and subcutaneous necrosis.
Necrotizing fasciitis follows an injury to the epidermis. In 45% of cases, it is not possible identify the site of the initial injury. [1] [2] [3] The extremities are the most commonly affected local, but the involvement of the trunk and perineum is related to the high mortality rate. 4, 5 Patients over 65 years old have the highest incidence of the disease. 1 Initially, the disease presents with a local edema. However, with the involvement of the surrounding tissues, local toxicity is triggered and simulates a cellulitis. But the patient presents with severe pain, disproportionate to the skin lesion. The progression of the margins of erythema at greater than 1 cm/h speed is an important signal to the diagnosis in the early stages of necrotizing fasciitis. 6 With the evolution of the underlying necrotic process, serous blisters possibly becoming hemorrhagic can be observed.
Usually, fever, chills, hypotension, tachycardia, and altered level of consciousness are present. 2, 6 Acute renal failure is present in 35% of patients, coagulopathy in 29%, acute respiratory failure in 14%, and bacteremia in 46%. 7 The burning pain is the most prominent symptom, that can be observed in almost 100% of patients with necrotizing fasciitis. 8 The diagnosis is mainly clinical; it is essential that the physician has a high degree of suspicion. The average time between onset of symptoms and diagnosis is 2-4 days. 9 WBC count > 15,400 cells/mm 3 and serum level of sodium < 135 mmol/L have a sensitivity of 90% for necrotizing fasciitis. The specificity is 76% and the positive predictive value is 26%, and that only serves to exclude the disease. 10 Phosphocreatin levels > 600 IU/L have 58% sensitivity and 95% specificity. 11 MRI has high sensitivity (93-100%) for diagnosis. Liquefied tissue inflammation and edema around the fascia are detected by an increased signal on T2-weighted images and absence of attenuation of gadolinium in T1.
"The finger test" is a simple procedure, done under local anesthesia. The surgeon makes an incision of 2 cm to the deep fascia, and his/her gloved finger is inserted. The presence of liquefied subcutaneous tissue, absence of bleeding and poor adherence of subcutaneous tissue during blunt dissection define a positive test. A sample of tissue must be resected and sent to bacterioscopy, culture and anatomopathological examination.
Histologically, necrotizing fasciitis is characterized by suppurative focal necrosis of fascia, fat and nerves, edema of the fibrous septa and infiltration by polymorphonuclear cells.
The parenteral empirical antibiotic therapy can be initiated with imipenem, meropenem, ampicillin/sulbactam or piperacillin/tazobactam associated with clindamycin. The antibiotic is complementary to debridement.
In patients allergic to penicillin, ceftazidime, associated with clindamycin, is an option. 12 The mortality of necrotizing fasciitis ranges from 6% to 76%. 13 Patients over 60 years old have a high mortality rate. Thrombocytopenia, abnormal liver function, hypoalbuminemia, acute renal failure, and increased serum lactate are associated with mortality. 14 The mortality can reach 100% in non-operated cases and in the case of myonecrosis. 7 However, the mortality rate drops to 12% if the diagnosis and treatment are made in the first four days after the onset of symptoms. 15 
Conclusion
Necrotizing fasciitis is a severe infectious disease. It requires a high index of suspicion to initiate antibiotic therapy and debridement.
Despite the diagnosis of necrotizing fasciitis and the indication of debridement, blood dyscrasias precluded surgery in a timely manner, so there was no reversal of the clinical picture.
